Antisense oligonucleotides: strategies for delivery
- 1 December 1998
- journal article
- Published by Elsevier in Pharmaceutical Science & Technology Today
- Vol. 1 (9) , 377-386
- https://doi.org/10.1016/s1461-5347(98)00098-4
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Inhibition of Human Immunodeficiency Virus Type 1-mediated Cytopathic Effects by Poly(L-lysine)-conjugated Synthetic Antisense OligodeoxyribonucleotidesJournal of General Virology, 2008
- A rapid method for determining sequences in DNA by primed synthesis with DNA polymerasePublished by Elsevier ,2004
- Antisense oligonucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheresInternational Journal of Pharmaceutics, 1997
- Cloning, expression and pharmacology of the mouse 5‐HT4L receptorFEBS Letters, 1996
- Pharmacokinetics of Antisense OligonucleotidesClinical Pharmacokinetics, 1995
- Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayersInternational Journal of Pharmaceutics, 1994
- Cationic Lipids Improve Antisense Oligonucleotide Uptake and Prevent Degradation in Cultured Cells and in Human SerumBiochemical and Biophysical Research Communications, 1993
- Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirusBiochemical and Biophysical Research Communications, 1992
- Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulsesEuropean Journal of Cancer and Clinical Oncology, 1991
- Effect of ionic strength on the hybridization of oligodeoxynucleotides with reduced charge due to methylphosphonate linkages to unmodified oligodeoxynucleotides containing the complementary sequenceBiochemistry, 1989